These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21337362)

  • 41. A Note on Modelling Bidirectional Feedback Loops in Mendelian Randomization Studies.
    Hwang LD; Evans DM
    Behav Genet; 2024 Jul; 54(4):367-373. PubMed ID: 38822217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Causal null hypotheses of sustained treatment strategies: What can be tested with an instrumental variable?
    Swanson SA; Labrecque J; Hernán MA
    Eur J Epidemiol; 2018 Aug; 33(8):723-728. PubMed ID: 29721747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correcting the Standard Errors of 2-Stage Residual Inclusion Estimators for Mendelian Randomization Studies.
    Palmer TM; Holmes MV; Keating BJ; Sheehan NA
    Am J Epidemiol; 2017 Nov; 186(9):1104-1114. PubMed ID: 29106476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival Bias in Mendelian Randomization Studies: A Threat to Causal Inference.
    Smit RAJ; Trompet S; Dekkers OM; Jukema JW; le Cessie S
    Epidemiology; 2019 Nov; 30(6):813-816. PubMed ID: 31373921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survivor bias in Mendelian randomization analysis.
    Vansteelandt S; Dukes O; Martinussen T
    Biostatistics; 2018 Oct; 19(4):426-443. PubMed ID: 29028924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identifying the odds ratio estimated by a two-stage instrumental variable analysis with a logistic regression model.
    Burgess S;
    Stat Med; 2013 Nov; 32(27):4726-47. PubMed ID: 23733419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adding Mendelian randomization to a meta-analysis-a burgeoning opportunity.
    Niu W; Gu M
    Tumour Biol; 2016 Feb; 37(2):1527-9. PubMed ID: 26695146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mendelian randomization with Egger pleiotropy correction and weakly informative Bayesian priors.
    Schmidt AF; Dudbridge F
    Int J Epidemiol; 2018 Aug; 47(4):1217-1228. PubMed ID: 29253155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reporting methodological issues of the mendelian randomization studies in health and medical research: a systematic review.
    Islam SN; Ahammed T; Anjum A; Albalawi O; Uddin MJ
    BMC Med Res Methodol; 2022 Jan; 22(1):21. PubMed ID: 35034628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Instrumental variable analysis of multiplicative models with potentially invalid instruments.
    Shardell M; Ferrucci L
    Stat Med; 2016 Dec; 35(29):5430-5447. PubMed ID: 27527517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mendelian randomization and estimation of treatment efficacy for chronic diseases.
    Schooling CM; Freeman G; Cowling BJ
    Am J Epidemiol; 2013 May; 177(10):1128-33. PubMed ID: 23585329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma C-Reactive Protein and Abdominal Aortic Aneurysm: A Mendelian Randomization Analysis.
    Qin XY; Juan J; Xiang X; Wei YQ; Zuo SW; Huang T; Chen DF; Marshall R; Xiong J; Guo W; Hu YH
    Chin Med J (Engl); 2018 Nov; 131(21):2630-2633. PubMed ID: 30381605
    [No Abstract]   [Full Text] [Related]  

  • 53. [Causality can be shown with mendelian randomization. Cardiovascular risk relations tested with the method].
    Nilsson PM
    Lakartidningen; 2013 Apr 17-23; 110(16):832-5. PubMed ID: 23717930
    [No Abstract]   [Full Text] [Related]  

  • 54. Re: "credible mendelian randomization studies: approaches for evaluating the instrumental variable assumptions".
    Palmer TM; Ramsahai RR; Lawlor DA; Sheehan NA; Didelez V
    Am J Epidemiol; 2012 Sep; 176(5):457-8; author reply 458. PubMed ID: 22850793
    [No Abstract]   [Full Text] [Related]  

  • 55. Mendelian randomization: the use of genes in instrumental variable analyses.
    von Hinke Kessler Scholder S; Smith GD; Lawlor DA; Propper C; Windmeijer F
    Health Econ; 2011 Aug; 20(8):893-6. PubMed ID: 21612002
    [No Abstract]   [Full Text] [Related]  

  • 56. MR_predictor: a simulation engine for Mendelian Randomization studies.
    Voight BF
    Bioinformatics; 2014 Dec; 30(23):3432-4. PubMed ID: 25165093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimation and testing of the relative risk of disease in case-control studies with a set of k matched controls per case with known prevalence of disease.
    Moser BK; Halabi S
    Stat Med; 2012 Jan; 31(1):29-44. PubMed ID: 22162127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Eliminating Survivor Bias in Two-stage Instrumental Variable Estimators.
    Vansteelandt S; Walter S; Tchetgen Tchetgen E
    Epidemiology; 2018 Jul; 29(4):536-541. PubMed ID: 29652757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Using Mendelian randomization to determine causative factors in cardiovascular disease.
    Johansen CT; Hegele RA
    J Intern Med; 2013 Jan; 273(1):44-7. PubMed ID: 22928522
    [No Abstract]   [Full Text] [Related]  

  • 60. Designs combining instrumental variables with case-control: estimating principal strata causal effects.
    Shinohara RT; Frangakis CE; Platz E; Tsilidis K
    Int J Biostat; 2012 Jan; 8(1):. PubMed ID: 22499727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.